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Abstract and Keywords:
Excess androgen exposure during fetal life in the ewe permanently alters the number of
agouti-related peptide (AgRP) neurons and their projections, suggesting a possible
mechanism by which prenatal testosterone may contribute to insulin resistance and an
increased risk of obesity in women with polycystic ovarian syndrome (PCOS). Using
immunocytochemistry, we found a decrease of insulin receptors colocalized with AgRP
in the arcuate nucleus of the hypothalamus in prenatal testosterone treated sheep, but no
changes in colocalization with proopiomelanocortin (POMC). In addition,
characterization of leptin-induced phosphorylated signal transducer and activator of
transcription 3 (pSTAT3), a marker of leptin signalling, was mapped in the hypothalamus
and preoptic area of control sheep. We found that pSTAT3 colocalizes with POMC-ir
neurons, minimally with kisspeptin, and is not co-expressed with GnRH. Overall, these
results may lay the foundation for manipulation studies that will attempt to help address
the metabolic and reproductive deficits seen in women with PCOS.

Keywords:
AgRP, POMC, Insulin Resistance, Insulin Receptor, Polycystic Ovarian Syndrome, Ewe,
Leptin, pSTAT3, GnRH, Kisspeptin.
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Chapter 1: Literature Review and Introduction

PCOS

-

metabolic/reproductive dysfunction.

Fetal physiology and development are greatly influenced by gestational environment.
Factors present in this environment can lead to permanent structural and functional
changes in morphology and physiology [1]. In cases of environmental imbalances, fetal
development may be altered. Barker’s hypothesis proposes that such alterations are the
root origin of many diseases occurring in adult life [2], A classic example is that of fetal
testosterone (T) levels mediating sexual differentiation; a high level of testosterone at a
certain stage of development leads to masculinization of the male fetus [3], However, in
the event that a female fetus is exposed to excess levels of T during critical periods of
development, brain circuitry can become masculinized [4]. This effect of T during early
female fetal life is believed to play a role in the development of polycystic ovarian
syndrome (PCOS) [5].

PCOS is a disease of reproductive and metabolic dysfunction [6], It is a common
endocrine disorder of premenopausal women affecting 6-8% of the reproductive aged
females in the United States and is the leading cause of infertility [5]. There is much
heterogeneity in this disorder. To be diagnosed, a woman must suffer from at least two of
the following symptoms: i) intermittent or absent menstrual cycles, ii) hyperandrogenism,
or iii) polycystic ovaries, as determined by the Rotterdam criteria [7], In addition to being
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a reproductive disorder, PCOS is a metabolic disorder associated with increased risk of
obesity, insulin resistance, and hyperlipidemia [6].

PCOS symptoms are commonly observed in women with congenital adrenal hyperplasia,
a prenatal genetic disorder. In brief, these women have reduced 21-hydroxylase
enzymatic activity which impairs the conversion o f progesterone to 11-deoxy
corticosterone in the adrenal glands. Under disease circumstances, excess progesterone is
used for the production of androgens. Abnormal levels of androgen are typically
corrected for after birth by eliminating the excess androgens [8], However, majority of
these women develop PCOS in adulthood suggesting that the presence of excess
androgens during fetal development may lead to permanent phenotypic changes [9],
Specifically, prenatal exposure to androgens may have an organizational effect on the
brain circuits involved in reproductive and metabolic regulation.

In order to investigate the effects of prenatal androgen exposure on neural circuits
involved in reproduction and metabolism, our research group has developed a wellestablished prenatal T-treated sheep model o f PCOS [6]. Ewes provide many advantages
over traditional animal models: they have a long gestational period, their brains are more
developed at birth, similar to humans, and the neuroendocrine regulation of their estrous
cycle is similar to that of the human menstrual cycle. Moreover, ewes can easily and
repeatedly have their blood drawn to measure circulating hormone, without any acute or
chronic stress response. In addition, ewes treated prenatally with testosterone show
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permanent alterations that mimic the reproductive and metabolic symptoms of PCOS
such as polycystic ovaries, infertility, increased risk of obesity, and insulin resistance [6].

Overview o f Metabolic Circuitry
Body weight regulation is integral to the survival of vertebrates and is determined by
genetics, behaviour, and physiology. The resounding prevalence of obesity is increasing
worldwide and this epidemic is believed to reflect environmental factors, such as over
consumption and decreased physical activity, rather than genetics. Having excessive or
insufficient energy stores impairs fertility, and thus fecundity. Achieving and maintaining
energy balance requires establishing an equilibrium between energy intake and energy
expenditure. Various peripheral hormones act on the central nervous system, converging
on the hypothalamus, a brain area that highly regulates metabolism. It is in the
hypothalamus that stimulation or suppression of various neuropeptides control food
intake [10-11]. Having either a surplus of energy or deficiency determines how the body
reacts to achieve balance. In states of energy deficiency, the reaction would be consuming
food and/or decreasing movement. When the body has excess energy storage, the
response would be suppression of food intake and/or increased body movement [10].
Maintenance of body weight occurs over a long period of time and is regulated by two
main hormones, insulin and leptin. A chronic imbalance o f energy intake and expenditure
shifts the body to accumulate (with positive energy) or decrease (when the balance is
negative) body fat. Insulin and leptin attempt to compensate for this difference to achieve
equilibrium [12],
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Insulin
Acting in the brain as an anorexigenic signal, insulin is a metabolic hormone highly
correlated to energy balance. Insulin acts both acutely - to inhibit feeding behaviour, and
chronically - as it circulates in proportion to fat stores to influence body weight [13].
When a meal is consumed, blood glucose is increased. Subsequently, insulin is rapidly
secreted from beta cells in the islets of Langerhans in the pancreas to promote glucose
uptake from the blood [14]. Thus, during increased energy states, insulin secretion is
increased. Conversely, in reduced energy states, insulin secretion is decreased.

Insulin acts both peripherally and centrally. To enter the brain, insulin crosses the bloodbrain barrier (BBB), in levels proportional to circulating insulin, by a saturable receptormediated transport mechanism [15-17]. Insulin can also access the brain by
circumventricular regions which lack the BBB [18-19],

The concentration of insulin in the brain is influenced by diet in both animals and
humans. Eating increases insulin in the hypothalamus [20]. In a fasted state, brain insulin
levels are decreased [21-22], Central administration of animals with insulin causes a
decrease in eating in rodents, sheep, and nonhuman primates which over time leads to
reduced energy intake and thus decreased body weight [23].
Insulin receptors (IR) are distributed throughout the brain [24-26]. The highest
concentration of IR are localized in the cerebral cortex, cerebellum, hippocampus,
olfactory bulb and the hypothalamus, extensively in the arcuate nucleus of the
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hypothalamus (ARC) [27-28]. Insulin receptors are found abundantly in neurons, with
lower levels found in glia [22]. Insulin receptor mRNA is found in the somata of the
neurons, whereas protein is present in cell bodies and axon terminals [22, 29]. Various
populations of neurons in the brain that are involved in energy homeostasis express
insulin receptors.

Insulin receptor and Signaling Pathway
The insulin receptor consists of an extracellular alpha subunit that binds the insulin and an
intracellular beta subunit that relays the signal to the cell. Binding of insulin induces a
conformational change in the receptor inducing autophosphorylation of the b-subunit,
subsequently activating intrinsic tyrosine kinase activity of the receptor. Insulin receptor
substrate (IRS) proteins are then recruited to the plasma membrane, which become
phosphorylated on tyrosine residues, subsequently recruiting additional signalling
proteins regulated by various protein kinases [30]. The two major kinases involved are
phosphoinositide-3kinase (PI3K), and the mitogen-activated protein kinase (MAPK) [31
32]. Biological responses are then initiated through phosphorylation and activation of
these major cellular signal transduction cascades, which regulates gene transcription
implicated in growth and metabolism as depicted in Figure 1.1 [33-35].
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Figure I. I Insulin Receptor and Signalling Pathways. Binding of Insulin to the a-subunit of the insulin
receptor activates tyrosine autophosphorylation of the [3-subunit and subsequent downstream signalling
pathways .Abbreviations: pY, phospho-tyrosine: IRS, insulin receptor substrates; MAPK, mitogen-activated
protein kinase; PI3K, phosphoinositide-3 kinase. (Modified from Chiu, S.L. 2010 [35])

Insulin Resistance
Weight gain is associated with increasing insulin resistance. To maintain normal blood
glucose levels, when tissue does not appropriately respond to physiologic concentrations
of insulin, higher concentrations of insulin are required. This characterizes insulin
resistance [36-38]. The increased insulin secretion as obesity progresses is believed to
prevent continued weight gain. However, when the pancreas secretes increased insulin to
compensate for defective glucose uptake, eventually the pancreatic beta cells become
dysfunctional due to this oversecretion. Exhaustion of the (3 cells to maintain the adaptive
increase in insulin leads to type II diabetes [39].

The presence o f insulin resistance is evident in women with PCOS, as marked by
impaired glucose transported into skeletal tissue [40-42], When matched for body mass
index (BMI) to control women, those with PCOS have far worse insulin resistance [43],
Treatment with insulin-sensitizing drugs decreases many of the symptoms experienced by
these women (metabolic, endocrine, ovulatory function, menstruation, fertility), even
without associated weight loss [44], Thus, it is believed that insulin resistance is an
important component in the development of PCOS and intensity of the phenotype.

Hyperandrogenemia is believed to be exacerbated by hyperinsulinema, which acts
synergistically with increased lutentizing hormone (LH) to increase androgen production
in theca cells of the ovary [45-47], This activates the enzyme P450cl7a in the ovary,
which is critical in the biosynthesis of androgens [48], Moreover, insulin suppress sex
hormone binding globulin (SHBG) produced by the liver, permitting an increase in
unbound plasma testosterone [49], 17p-hydroxy steroid dehydrogenase (17(3-HSD) is an
enzyme found in the liver, skin, and adipose tissue that catalyzes the conversion of
androstenedione (A) to T [50], Human adipose tissue is capable of synthesizing
androgens by 17(3HSD, and this enzyme is found to have increased expression in obesity
[51]. This may therefore contribute to site specific androgen excess in the obese
population. Individuals that have body fat distributed to visceral and abdominal areas
experience enhanced insulin resistance compared to individuals with mainly
subcutaneous fat depots. More than 50% of women with PCOS suffer from both insulin
resistance and abdominal obesity [52] . Female rhesus monkeys treated in utero with
androgens develop primarily visceral adiposity in adulthood independent of being obese
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Leptin
Leptin is a protein hormone, encoded by the ob gene, that is secreted from adipose tissue
into circulation in proportion to fat stores [54]. Levels of circulating leptin serve as an
indicator for the state of peripheral energy stores to signal the brain to suppress food
intake and permit energy expenditure/thermogenesis [55], Leptin operates in a regulatory
feedback loop to maintain body weight. In states of weight gain and increased fat depots,
leptin secretion is increased from adipose tissue and acts on leptin receptors in the brain
to stimulate the sympathetic nervous system, therefore decreasing food intake and
increasing energy output in attempt to lose weight and maintain energy balance. In states
of weight loss, leptin secretion is decreased and this permits increased food intake and
decreased energy expenditure to gain weight and achieve balance. Leptin does not act
over the short-term in proportion to meal intake, but its effects are observed over time
when fat content is increased, plasma leptin also increases [56].

The leptin receptor gene transcript is alternatively spliced to produce multiple
isoforms[57]. The short form of the leptin receptor (LepRa) is expressed in the choroid
plexus and transports leptin into the CSF by a saturable transport system past the BBB.
Leptin also enters the brain through circumventricular organs that lack BBB. The long
form of the leptin receptor (LepRb) is implicated in the actions of metabolic regulation
and localization of the leptin receptor in various animals are shown in Table 1.1 [54].
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Table 1.1 Leptin Receptor/pSTAT3 Localization expression in the mouse, rat, sheep, and monkey.

Animal
Mouse

Rat

Sheep

Monkey

Leptin Receptor
LepRb
Hypothalamus (ARC, PMv, DMH, LHA, VMH,
median preoptic nucleus,
periventricular nucleus,
PVN(only a few)
VTA
Dorsal raphe nucleus
Periaqueductal gray
Cortex (weak staining)
Hippocampus (weak staining)
NTS (low to moderate staining) [58]
(LepRb)
Hypothalamus - (PMv, VMN, ARC, DMN,
LHA)
RCA
Medial mammillary nucleus
Nucleus of the lateral olfactory tract
Substantia nigra pars compacta
Medial and lateral geniculate nuclei
Hippocampus
Frontal cortex
Cerebellum (purkinge and granular cell layers)
r59i
LepRb
Choroid plexus
Hypothalamus (PVN, VMH, and ARC)
Hippocampus
Cerebral cortex,
POA
BnST [62]
(LepR - extracellular domain, thus all isoforms)
Choroid plexus
Hypothalamus (ARC, VMN, LHA, PMv,
periventricular nucleus)
RCA
Medial mammillary nucleus
Median eminence
BnST
mPOA
Lateral tuberal nuclei
Tuberomammillary nucleus
Periformical area
Dorsal raphe nucleus
Anterior pituitary [63]

Leptin induced pSTAT3-ir
Hypothalamus (ARC, PMv,
DMH, LHA, VMN,
median preoptic
nucleus)
VTA
PAG
NTS [58]

Hypothalamus (ARC,
VMN,
DMN, PMv, LHA
(very few) [60]
VTA[61]

Hypothalamus (ARC,
VMN, DMH)
POA [present study]

N/A
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Leytin Signalling Pathway
The appetite stimulatory and inhibitory neurons of the ARC are key targets of leptin as
they both express high affinity leptin receptors [64-65]. Binding of leptin to the
extracellular domain of its receptors mediates the activation of the intracellular associated
Janus Kinase (JAK) resulting in JAK2 autophosphorylation on tyrosine residues [55].
This is a crucial step in leptin signalling as LepRb does not have any enzymatic activity
of its own [66]. Activated JAK stimulates the phosphorylation of residues on the
intracellular domain of the LepRb Tyr985, Tyrl077, and Tyrl 138. When phosphorylated,
each of these residues recruits downstream signalling proteins. Signal transducer and
activator of transcription (STAT) 3 is recruited to the phosphorylated Tyrl 138 residue as
depicted in Figure 1.2. This recruitment mediates STAT3 phosphorylation at site
Tyr705.This phosphorylation activates STAT3. Activated STAT3 translocates to the
nucleus activate transcription of their target genes [67].
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Figure 1.2. Long form of Leptin receptor and signalling pathway. Binding of leptin to the extracellular
domain of the long form of the leptin receptor mediates phosphorylation of the intracellular domain of the
receptor and results in transcription of target genes. Abbreviations: LRb, Leptin Receptor b; p, phosphotyrosine;Jak2 Janus Kinase 2, STAT3, signal transducer and activator of transcription 3. (Adaptedfrom
Villanueva, E.C., Int. J. Obes, 2008)

Activated LepRb can also recruit STAT5 via the phosphorylated Tyrl077 site or
Tyrl 138. While the importance of pTyrl 138 is unclear, recruitment to p-Tyrl077
mediates induces the phosphorylation of STAT5 at site Tyr694 [68], A second tyrosine
residue, Tyr985, is phosphorylated when leptin binds to LRb, and this serves to recruit
suppressor of cytokine signalling (SOCS3) which contributes to inhibition of leptin action
[69],
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Rodents and humans lacking leptin or its receptor are obese, hyperphagic, have a lowered
metabolic rate, and are infertile [70-71], A knock-in mouse model of LepRb SI 138, in
which a serine residue replaces tyrosine, inhibits pSTAT3-dependent actions. These
animals are obese and hyperphagic, but are fertile and do not suffer from severe diabetes
[72-73],

Insulin and Leptin involvement with Reproduction
Fertility is dependent on nutrition and stored energy availability. If energy reserves are
insufficient, the reproductive axis is suppressed and appetite is stimulated to compensate.
Caloric restriction not only decreases insulin secretion, it also reduces levels of the
gonadotropins, lutenizing hormone (LH) and follicle stimulating hormone (FSH) [74],
Insulin and leptin are believed to be the main links between metabolism and the
reproductive system [75-76],

Gonadotropin releasing hormone (GnRH) neurons are the final common pathway
regulating reproduction by the brain [77], Neuron-specific knockout of the insulin
receptor (NIRKO) mice exhibit obesity, reduced LH secretion and thus have impaired
ovarian follicle maturation and spermatogenesis in the female and male, respectively [78].
However, it has not yet been shown in vivo that (GnRH) neurons express IR, suggesting
that the influence of insulin may be via other sets of afferent neurons. Similarly, GnRH
neurons do not express leptin receptors, however, animals devoid of leptin or the receptor
are hyperphagic, obese and infertile [79-80], Leptin activates the neuroendocrine
reproductive axis in many species including rodents and primates by stimulating GnRH
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and LH secretion, and because GnRH cells lack LepRb this influence is believed to be
indirect through other neurons [63, 81-83],

Steroid feedback control of GnRH by circulating gonadal hormones, such as estradiol and
progesterone, is also mediated by afferent neurons, since GnRH neurons do not express
the subtypes of gonadal steroid receptors involved in reproduction [84], A key population
of afferent neurons involved in relaying the influence of gonadal hormones onto GnRH
neurons are those that express the neuropeptide, kisspeptin [85-87], GnRH is directly
stimulated by kisspeptin, and GnRH neurons express the kisspeptin receptor [88-89],
Mutations of the kisspeptin receptor result in reproductive dysfunction in mice and
humans [85-86], Kisspeptin neurons are predominantly found in two areas, the ARC and
the preoptic area (POA). In the ARC, kisspeptin cells colocalize two other distinct
neuropeptides, neurokinin B (NKB) and dynorphin (DYN), and have been abbreviated as
“KNDy” (kisspeptin, neurokinin B/dynorphin) neurons. NKB and dynorphin, along with
kisspeptin, have been strongly implicated in steroid feedback control of GnRH neurons
[90], and KNDy neurons highly coexpress estrogen-a receptors, progesterone receptors,
and androgen receptors [91-97], In sheep, KNDy neurons directly contact cell bodies and
dendrites of GnRH neurons in the POA and MBH to relay steroid hormone signals
important for the estrous cycle and thus reproduction. In the sheep and other species,
kisspeptin neurons are also located in the POA, and approximately 50% of cells in this
rostral population coexpress the estrogen receptor-a but, unlike KNDy cells, they do not
coexpress NKB or DYN [98],
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Since GnRH neurons are devoid of leptin receptors, it is presumed that leptin links
metabolism to reproduction by indirectly regulating GnRH through upstream neurons.
Nutritional status influences kisspeptin expression. When fasted, kisspeptin mRNA is
suppressed in rodents [99-100], In addition, kisspeptin mRNA is increased when leptin is
centrally administered [101]. However, there have been discrepancies in determining how
leptin acts to stimulate GnRH, whether through a direct or indirect mechanism on
kisspeptin neurons. The extent of LepRb coexpression with kisspeptin has been debated.
In the mouse, it has been reported that the AVPV kisspeptin neurons do not coexpress
LepRb, but that up to 40% of ARC kisspeptin neurons coexpress LepRb [102]. In
contrast, through the use of transgenic mouse models, no coexpression of LepRb with
kisspeptin was found in the anteroventral periventricular nucleus (AVPV) and
coexpression of only 5-6% in the ARC [103], In addition, the use of reporter genes and
pSTAT3-ir demonstrated little or no evidence of leptin-induced pSTAT3 in the AVPV or
ARC kisspeptin neurons [104], The differences may lie in techniques used, where Louis
et al and Cravo et al. employed multiple techniques, including transgenics, IHC and
qPCR, the study by Smith et al. used dual in situ hybridization, which potentially may
lead to more false positives due to the nature of the signals.

AsRP/POMC
The main neuronal circuit regulating metabolism is located in the hypothalamus.
Specifically, peripheral signals are hypothesized to act on the neurons in the arcuate
nucleus (ARC) of the hypothalamus which play critical roles in regulating appetite and
body weight [105]. The ARC integrates various hormonal signals to control feeding.

Within the ARC, there are two populations of neurons expressing distinct neuropeptides
that have been implicated in anorexigenic and orexigenic processes. One population of
neurons are involved in appetite suppression. These catabolic neurons express the
neuropeptides, proopiomelanocortin (POMC) and cocaine and amphetamine regulated
transcript (CART) [106]. The second population plays a role in appetite stimulation.
These anabolic neurons express two neuropeptides, agouti-related peptide (AgRP) and
Neuropeptide Y (NPY) [105].

POMC is cleaved post-translationally which results in smaller peptides such [3-endorphin
and the a- and y- melanocortin stimulating hormones (MSH) [107]. The role of
melanocortins in energy homeostasis is mediated by signalling of a-MSH through the
melanocortin receptors, MC3R and MC4R, located in the hypothalamus. Specifically, aMSH is released during high food intake/low energy use, and acts to suppress appetite
[107]. MC3R are found on POMC-expressing neurons in the ARC while MC4R are
expressed in the hypothalamus, specifically in the paraventricular nucleus, the
dorsomedial hypothalamus, and the lateral hypothalamic area, in addition to the thalamus,
hippocamnpus, spinal cord, and cortex [108-109].

Peripheral administration of a potent melanocortin agonist, MTII decreases fat intake and
reverses obesity [110-111]. In addition, in rats the nonselective melanocortin receptor
antagonist SHU9119 diminishes the effect of leptin and increases body weight and food
consumption [112]. POMC mRNA and immunoreactive neuron expression are also
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affected by diet. In sheep subjected to diet-induced obesity, the number of POMC-ir
neurons are significantly increased in the ARC compared to controls (Sheppard, K.M.
Abstract # 2008-13219-SFN). In food restricted lambs, POMC mRNA was significantly
decreased in the ARC, in addition to su p p ressed LH p u lsatile secretion [113]. This is in
contrast to findings in adult sheep where food restriction did not induce a change in
POMC mRNA in the ARC compared to ad libitum fed animals, although there was a
significant difference in body weights [114-115]. [They did not differentiate between
Rostral/Middle/C audal]

Genetic manipulations also demonstrate the importance of POMC in metabolic control of
energy balance. Null POMC mice (-/-) exhibit hyperphagia, are markedly obese and have
a lower basal metabolic rate [116]. In addition, POMC knockout mice preferentially eat a
high fat diet compared to wild type mice [117]. Humans with POMC mutations are obese
and hyperphagic [118]. Null MC4R mice (-/-), which lack the receptor implicated in food
intake, are obese and hyperphagic [119]. Humans with MC4R mutations are also obese
[ 120],

AgRP is a 132 amino acid protein encoded by the AgRP gene [114]. AgRP neurons have
been strongly implicated in the regulation of body weight and feeding. In the brain, AgRP
neuropeptide is expressed in the ARC of the hypothalamus and the subthalamus. In
rodents and sheep, centrally administered AgRP has been shown to increase food intake
[121-122], In rodents, chronic exposure to exogenous AgRP leads to continued

hyperphagia resulting in obesity [123]. Changes in AgRP expression have also been
shown in different diet models. Sheep fed an ad libitum diet have decreased AgRP
neuron expression [122] (Sheppard, K.M. Abstract # 2008-13219-SFN) while those fasted
have increased AgRP mRNA expression and immunolabelled neurons [122, 124],

AgRP-deficient mice have a lean phenotype that is age dependent. This develops due to
increased energy expenditure [125], This age-dependence comes from studies showing
that targeted gene disruption of AgRP and/or NPY show no phenotype disturbing energy
homeostasis. In adult mice, diphtheria toxin mediated depletion of AgRP neurons induced
prominent anorexia [126-127]. Therefore the compensatory actions that occur in neonates
is not evident in the adult loss of AgRP. The mechanism regulating this compensatory
action has not fully been elucidated. These well characterized changes in AgRP
expression and food intake are proposed as an adaptive mechanism to regulate energy
intake and expenditure depending on current peripheral reserves and central
neurotransmitter expression.

Interactions between A eR P and POMC neurons
AgRP-expressing neurons innervate POMC-expressing neurons and release yaminobutyric acid (GABA) to inhibit the neuronal activity of POMC-expressing neurons
[128].The appetite stimulatory neuropeptide AgRP is a competitive antagonist of a-MSH
to MC3R and MC4R where binding of AgRP to these receptors increases appetite and
leads to increase food intake and decreased energy expenditure [105], AgRP has also
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been proposed act as an inverse agonist, thus exerting its effect on MC3R/MC4R
independent of the presence of a-MSH [129-131] (Summarized in Figure 1.3).
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Figure 1.3. Summary of the appetite regulatory circuitry in the ARC. Abbreviations'. ARC, arcuate nucleus;
3V, third ventricle; AgRP, agouti-related peptide; POMC, proopiomelanocortin; MCR3, melanocortin
receptor 3; MCR4, melanocortin receptor 4; PVN, paraventricular nucleus; LH, lateral hypothalamus,
DMH, dorsomedial hypothalamus. (Modifiedfrom Barsh and Schwartz, 2002)

Effect o f Insulin on AgRP and POMC
Insulin injected into the third ventricle (3V) of rats increases POMC mRNA expression,
which is reversed when injected with a melanocortin antagonist [132], In addition, insulin
decreases food intake and body weight. Administration of insulin to the third ventricle of
male rats fed a low fat diet upregulates POMC mRNA compared to those on a high fat
diet, independent of adiposity and body weight [133], Insulin prevents the decrease of
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POMC reporter activity by the transcription factor forkhead box-containing protein of the
O subfamily (FoxO)-l, and inhibits the increase of AgRP reporter activity [134] In
addition, a cell line used to directly test the effect of insulin on AgRP neurons showed
that insulin infusion repressed AgRP mRNA expression [135], Insulin receptors have
been observed to colocalize with NPY neurons in the chick infundibular nucleus of the
hypothalamus, equivalent to the mammalian ARC [136], NPY and AgRP are colocalized
in almost all neurons in mice (94% in fed mice and 99% in fasted mice) [137], Greater
than 95% of AgRP neurons colocalized NPY in the sheep ARC [138]. Although insulin
acts anorexigenically metabolically, as does a-MSH, insulin hyperpolarizes both AgRP
and POMC neurons, thus silencing their activity [34],

In mice, in situ hybridization data shows that up to 36% of POMC neurons in the ARC
express IR, with a distinct rostrocaudal distribution. Coexpression was observed more
medially near the third ventricle in rostral ARC while more lateral coexpression was
observed in the caudal ARC. Electrophysiology was performed in the same experiment,
and showed that with the addition of insulin, 10 of 40 POMC neurons were hyperpolarized
while the remainder were unaffected. The neurons that were silenced by insulin were
observed in more rostral areas of the ARC, while none were observed caudally [139], In
contrast, dual immunohistochemistry in rats revealed that 90% of POMC neurons
colocalized the insulin receptor-{3; colocalized cells were located throughout the ARC, but
distributed primarily in the rostral division [132], After addition of insulin to mice, all
AgRP neurons tested were hyperpolarized. When insulin receptors were ablated from
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AgRP neurons specifically, infusion of insulin failed to hyperpolarize all AgRP neurons
tested [140].

Deletion of neuronal insulin receptors in mice resulted in increased food intake, body
weight, plasma leptin, diet-sensitive obesity, insulin resistance, and infertility [78], In
adult rats, the use of lentiviral downregulation of the insulin receptor in the hypothalamus
resulted in increased obesity, leptin resistance, decreased leptin-induced pSTAT3, in
addition to deficits in context memory [141]. When insulin receptors were specifically
inactivated in AgRP neurons of the ARC of mice, there were no differences in food
intake, body weight, plasma leptin, diet-sensitive obesity, insulin resistance, and
infertility. However, ARC-specific AgRP insulin receptor knockout mice were unable to
suppress hepatic glucose production in response to insulin. Moreover, increased AgRP
neuropeptide expression was observed in this animal model compared to controls. Similar
to insulin receptor inactivation in AgRP neurons, when insulin receptors were inactivated
in POMC neurons of the ARC of mice, there was no difference in metabolic phenotype
compared to controls. In addition, neuropeptide expression of POMC did not differ [140].
Thus, in addition to AgRP neurons, other neuronal cell groups must be involved in
conferring the metabolic phenotype observed in the neuronal insulin receptor knockout
mouse.
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Figure 1.4. Effect of Insulin on metabolic neuronal circuitry in the ARC. Abbreviations: ARC, arcuate
nucleus; 3V, third ventricle; AgRP, agouti-related peptide; POMC, proopiomelanocortin; MCR3,
melanocortin receptor 3; MCR4, melanocortin receptor 4; PVN, paraventricular nucleus; LH, lateral
hypothalamus; DMH, dorsomedial hypothalamus; *, effect of insulin on POMC mRNA expression.
(Modifiedfrom Barsh and Schwartz, 2002)

Effect ofLeptin on AgRP and POMC
Leptin / pSTAT3 on POMC
Administration of leptin increases POMC mRNA, depolarizes POMC neurons and
increases axonal firing [65], In contrast, leptin reduces AgRP mRNA [142] and
hyperpolarizes AgRP neurons [143]. Binding of STAT3 to the POMC promoter increases
recruitment of histone acetylases and thus increases POMC mRNA [144], In contrast,
AgRP is upregulated by leptin deficiency [145] and binding of STAT3 to the AgRP

22
promoter increases histone deacetylases and decreases AgRP expression [134]. The
combined effect of leptin on POMC and AgRP acts to decrease food intake and increase
energy expenditure.

If was found that 35% of POMC neurons were observed to coexpress LepRb mRNA in
female rats [146]. In addition, after peripheral injection of leptin in rats, 37% POMC
neurons were pSTAT3 positive. There was a higher percentage of colocalization in the
rostral ARC [147]. There is a distinct topographic distribution of the subset of POMC
neurons that are activated by leptin, as revealed by Fos expression. POMC neurons that
are activated by leptin are more laterally located in the rostral ARC while in the caudal
ARC they are located medially, closer to the third ventricle. Injection of leptin
depolarized 16 of 46 POMC-GFP neurons, and the rest were unaffected [139] - leptin and
insulin may act on distinct subsets of POMC neurons in the hypothalamus, and thus, may
have opposite effects. Specific knockout of STAT3 in POMC neurons diminished POMC
expression, increased in fat pad mass, increased food intake and resulted in a modest
increase in body weight [148],

Leptin / STAT3 on AgRP
In mice, dual in situ hybridization studies indicate that between 10-25% of AgRP neurons
colocalize with LepRb in the ARC [142], It was reported that approximately 50% of NPY
neurons colocalize LepRb (almost all NPY neurons coexpress AgRP), and NPY mRNA
expression is increased by fasting [149],
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Binding sites for STAT3 are located on the AgRP gene promoter [150], Mice with a
panneuronal knockout of STAT3 are hyperphagic. diabetic, obese, have reduced energy
expenditure and increased AgRP mRNA expression [151]. However, mice that lack
STAT3 in AgRP neurons do not show altered AgRP mRNA expression with leptin
infusion [12]. In contrast, it has been shown that AgRP neurons are important for
locomotor activity, but not food intake, as observed in mice with a constitutively active
STAT3 in AgRP neurons. Thus, activation of STAT3 in AgRP neurons can affect energy
expenditure independently of its effects on AgRP mRNA (Summarized in Figure 1.5)
[152].

Effect of Leptin

r
\

Second
Sei
order

(PVN
nneurons
ei
\ kk nei
DMH, LH)

\

\

A

r

4
»
V1CR4

f r ) M CR3
n

Insulin Receptor

11

Leptin Receptor

Leptin

Figure 1.5. Effect of Leptin on metabolic neuronal circuitry in the ARC. Abbreviations: ARC, arcuate
nucleus; 3 V, third ventricle; AgRP, agouti-related peptide; POMC, proopiomelanocortin; MCR3,
melanocortin receptor 3; MCR4, melanocortin receptor 4; PVN, paraventricular nucleus; LH, lateral
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Rationale for Experiments
Previously, our laboratory demonstrated that the appetite stimulatory peptide, AgRP, and
the appetite suppressing peptide, POMC, are located in two distinct populations in the
ARC in normal ewes. We also found, similar to what is seen in rodents, that the appetite
stimulatory peptides, AgRP and NPY are co-expressed in the same neurons, whereas, the
appetite suppressing peptides, CART and POMC, are co-expressed in the same neurons
[138]. Interestingly, we also found that both POMC/CART and AgRP/NPY-expressing
neurons contain androgen receptors [138], These findings indicate a possible site of
action for androgenic regulation of the metabolic neuronal circuitry as well as a potential
for disturbance by excess prenatal androgen exposure.

Preliminary data from our lab has shown that a majority of both AgRP and POMC
neurons express insulin receptors in the ewe ARC [Lehman, M.N. preliminary data]. It is
also known that prenatal testosterone treated sheep are insulin resistant [153]. Insulin
resistance occurs when cells become less sensitive to the effects of insulin to absorb
glucose. Greater amounts of insulin are then required to sequester glucose from the blood
[14]. In normal neuronal metabolic circuitry, increases in insulin are associated with
increased POMC expression [14]. By contrast, insulin has been shown to decrease AgRP
expression in the rodent ARC [154]. By doing so, insulin decreases feeding and is part of
a homeostatic loop in metabolism. Prenatal T sheep do not differ in POMC expression
compared to control sheep, however, they display a nearly two-fold increase in the
number of AgRP neurons. We hypothesize that this increase in AgRP in prenatal T
animals is due to decreased insulin receptor expression, specifically within AgRP
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neurons. A decrease in receptors would impair the ability of insulin to target AgRP
neurons, and inhibit AgRP mRNA and peptide expression. Since POMC neurons are not
altered by prenatal T treatment, we hypothesize that insulin receptor expression within
POMC neurons will remain unchanged compared to control animals. Insulin receptor
protein expression in the hypothalami of the ewe has not previously been examined.

An increase in adipose tissue, as observed in excessive weight gain and obesity, leads to
increases in circulating leptin. Circulating leptin then binds to its receptors on POMCexpressing neurons, leading to the activation of the above-mentioned signal transduction
cascade. Activated STAT3 translocates to the nucleus to activate transcription of target
genes, such as POMC[55]. The POMC post-translational product binds to its receptors,
which initiates downstream signaling to suppress appetite, leading to decreased feeding
and promotion of weight loss [107]. In addition, leptin acts to inhibit the expression of
AgRP as well as the release of GABA from AgRP-expressing neurons [128]. Leptin thus
leads to increased energy expenditure and appetite suppression. Our goal is to
characterize leptin signalling in the ewe brain via leptin-induced pSTAT3 expression and
to investigate possible colocalization of leptin-induced pSTAT3 within neurons
implicated in metabolism and reproduction. This work will lay the foundation for future
studies in prenatal T sheep to further elucidate the metabolic and reproductive
dysfunctions exhibited in this model of PCOS. We hypothesize that leptin-induced
pSTAT3-ir will be distributed in areas o f the brain that have been shown to express the
signalling form o f the leptin receptor. In addition, we further hypothesize that pSTAT3ir will colocalized within POMC neurons, but not within GnRH or kisspeptin neurons,
since the latter cell types appear to lack LepRb.
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Chapter 2: Materials and Methods

2.1 Prenatal Testosterone Experiment
2.1.1 Animals and experimental groups
Suffolk ewes were cared for at the University of Michigan Sheep Research Facility (Ann
Arbor, Ml). Details of housing, nutrition, breeding and lambing have previously been
described [155-157], Prenatal treatment with hormones were administered in utero via
injections to the pregnant mother between days 30 and 90 of gestation of a 147 day
gestation period. Each of the three experimental groups consisted of the female offspring
of these hormone injected pregnant ewes and included: female offspring treated with
Testosterone (T; n=5), Testosterone with simultaneous treatment of flutamide (T+F; n=6),
and flutamide alone (F; n=6). Control groups (n=6) did not receive any treatment as it has
been previously documented that there are no differences between untreated and vehicle
treated controls [157]. If twin births occurred, only one offspring from the pair was
included. All procedures conducted were approved by the Institutional Animal Care and
Use Committee of the University of Michigan and were in accordance with the National
Research Council’s Guide for the Care and Use of Laboratory Animals.

2.1.2 Hormones
T (Testosterone-propionate; Sigma-Alderich) was injected intramuscularly twice weekly
(100 mg/2ml dissolved in cottonseed oil; Sigma-Aldrich, St. Louis, MO). Previous
analysis of maternal and fetal blood circulation has demonstrated that this dosage of T
levels is similar to adult males and fetal males, respectively [158]. Animals in the F group
received daily injections of Flutamide (15mg/kg, Sigma-Alderich) administered
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subcutaneously dissolved in dimethylsulfoxide (400mg/ml, Sigma-Aldrich)). Animals in
the T+F group received testosterone propionate as described above in addition to daily
injections of Flutamide.

2.1.3: Tissue Collection
Brains were collected during the breeding season when ewes were at two years of age. 3
4 weeks prior to tissue collection, endogenous steroid levels were normalized by
ovariectomy and 17 (3-estradiol implants to mimic follicular phase of the estrous cycle (as
previously described in [159]) At time of tissue collection, all ewes received two
intravenous injections (at 10 min intervals) of 25,000 U heparin (catalog# 402588B;
Abraxiz Pharmaceuticals, Schumberry, IL). Ewes were anaesthetized intravenously with
sodium pentobarbital (390 mg/ml/kg; Fatal Plus, Vortech, Dearborn, MI) and killed by
rapid decapitation. Ewe heads were perfused through the internal carotid artery with 6L
4% paraformaldehyde (Sigma- Aldrich) dissolved in 0.1 M phosphate buffer (PB; SigmaAldrich) containing 0.1% sodium nitrate (Sigma- Aldrich), and 10 U/ml heparin (Abraxiz
Pharmaceuticals). Brains were submerged in the same fixative at 4°C for 18hr. Blocks of
tissue containing hypothalami were then kept in 30% sucrose (Caledon, Georgetown,
Ont., Canada) at 4°C and sectioned coronally (45 pm) using a freezing microtome
(Microm, Walldorf, Germany) into 12 parallel series for each animal. Sectioned tissues
were stored in cryoprotectant (30% ethylene glycol, 0.1% sodium azide, 30% sucrose in
PB) at -20°C until further processing.
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2.1.4: Immunohistochemistry: Triple-label Immunofluorescence fo r AgRP/IRfi/POMC
Sections through the hypothalamus and preoptic area of each animal were processed
using immunohistochemistry. All incubations occurred at room temperature with gentle
agitation. Free floating sections were rinsed thoroughly with 0.1 M phosphate-buffered
saline (PBS) between incubations. Tissue was incubated for 10 min in 1% H2 O2 (FisherScientific, Fair Lawn, New Jersey) then blocked for an hour in incubation solution (PBS
containing 0.4% Triton-X (Fisher -Scientific) containing 20% normal goat serum (NGS,
Jackson ImmunoResearch, West Grove, PA). Sections were incubated overnight (17
hours) with antibody specifically recognizing AgRP (raised in Guinea Pig, 1:800 in
incubation solution with 4% NGS; Antibodies Australia, catalogue # GPAAGRP.l, Lot #
AS506), and with goat anti-guinea pig Alexa 488 (1:100 in incubation solution with 4%
NGS, 1 hour, Molecular Probes, Inc., Carlsbad, CA). Next, sections were incubated
overnight with antibody recognizing IR-P (raised in Rabbit, 1:300 in incubation solution
with 4% NGS, Santa Cruz, C-19, SC-711), with biotinylated goat anti-rabbit (1:500 in
incubation solution with 4% NGS, 1 hour, Vector Laboratories, Burlingame, CA, USA),
ABC-elite (1:500 in PBS, 1 hour, Vector Laboratories) biotinylated tyramine (BT; 1:250
in PBS with 1 pi of 3% H2 O2 / 1T1L, 10 minutes, Perkin Elmer Life Sciences, Woodbridge,
Ont., Canada), and Alexa 555 conjugated streptavidin (1:100 in PBS, 30 minutes,
Molecular Probes). Finally, sections were incubated with antibody specifically
recognizing POMC (raised in rabbit, 1:4,000 in incubation solution with 4% normal
donkey serum, Phoenix Pharmaceuticals, Burlingame, CA, USA, catalogue # FI-029-30)
and donkey anti-rabbit Cy5 (1:100 in PBS, 30 minutes, Molecular Probes). Sections were
mounted on plus charged slides and coverslipped with gelvatol [160].
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Specificity of primary antibodies for POMC and AGRP has previously been
demonstrated in sheep hypothalamic sections (6). Pre-absorption of IRp antibody with its
corresponding peptide antigen (Santa Cruz) at concentration of 10 pg/ml for 24 hours at
4°C eliminated all immunoreactive staining. Finally, elimination of any of the primary
antibodies while performing all other steps of the protocol, prevented any staining for that
specific antibody, demonstrating lack of cross-reactivity.

2.1.5. Analysis
Expression and co-expression of AGRP, POMC, and IRp-immunoreactivity (-ir) were
analyzed using confocal microscopy (as previously described in 8). Using a Zeiss LSM510 laser-scanning confocal microscope system (Zeiss, Heidelberg, Germany) images of
the arcuate nucleus of the hypothalamus (ARC) were captured in Z-stacks of 3 pm optical
sections. Alexa 555 fluorescence (IRp) was imaged with a HeNel laser and a 543 nm
emission filter. Alexa 488 fluorescence (AGRP) was imaged with an Argon laser and a
488 nm emission filter. Cy5 fluorescence (POMC) was imaged with a HeNe2 laser and a
633 nm emission filter. Cell counts were performed for each animal in rostral, middle,
and caudal divisions of the ARC. Per animal, an average of 85 AgRP-ir and 80 POMC-ir
cells were analyzed for co-expression of IRp-ir in each of the three rostral-caudal levels
of the ARC and were averaged per animal. Percentages of the AGRP- or POMC-ir
neurons that co-expressed IRp-ir were calculated per animal. Differences between groups
were determined using Two Way Analysis of Variance to test differences between ARC
rostral-caudal levels and between treatment groups. For pairwise comparisons between
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treatment groups within each rostral-caudal level, Dunn’s Method or Fisher LSD Method
post hoc tests were performed. 95% confidence levels were applied to all tests.

2.2 Mapping of leptin responsive neurons

2.2.1 Animals and experimental groups
Adult Suffolk ewes (2.5-3 years of age) were cared for at the University of Michigan
Sheep Research Facility (Ann Arbor, MI). Details of housing and nutrition have
previously been described [155-157]. Two hours prior to sacrifice, sheep were
administered peripheral injections (i.v.) of leptin (0.8mg/ml in 15mM HC1 and 7.5mM
NaOH (pH 5.2) human recombinant leptin, Sigma-Alderich catalogue # L4146; n=4).
Control ewes received i.v. injection of vehicle (0.5 ml HC1 and 0.3 ml NaOH; n= l) or
were handled (n=3).

2.2.2 Tissue Collection
At time of tissue collection, all ewes received two intravenous injections (at 10 min
intervals) of 25 000 U heparin (Abraxiz Pharmaceuticals). Ewes were heavily
anaesthetized intravenously with sodium pentobarbital (390 mg/ml/kg; Fatal Plus,
Vortech, Dearborn, Ml) and killed by rapid decapitation. Ewe heads were perfused
through the internal carotid artery with 6L 4% paraformaldehyde (Sigma-Alderich)
dissolved in 0.1 M sodium phosphate buffer (PB; Sigma-Alderich) containing 0.1%
sodium nitrate (Sigma-Alderich) and 10 U/ml heparin. Brains were submerged in the
same fixative at 4 °C for 18hr. Blocks of tissue containing hypothalami were then kept in
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30% sucrose (Caledon) at 4°C and sectioned coronally using a freezing microtome
(Microm, Walldorf, Germany) into 12 parallel series (45 pm) for each animal. Sectioned
tissues were stored in cryoprotectant (30% ethylene glycol, 0.1% sodium azide, 30%
sucrose in PB) at -20°C until further processing.

2.2.3. Dual-label immunoperoxidase staining fo r GnRH/pSTAT3, Kissl/pSTAT3,
POMC/pSTA T3
Sections through the hypothalamus of each animal were processed using
immunohistochemistry. All incubations occurred at room temperature with gentle
agitation. Free floating sections were rinsed thoroughly with 0.1 M sodium phosphatebuffered saline (PBS) between incubations. Tissue was incubated in 100% methanol (10
min; Caledon) and 30% H2 O2 (10 min; Fisher Scientific), then blocked for an hour in
incubation solution (PBS containing 0.4% Triton-X (Fisher Scientific) containing 4%
normal goat serum (NGS, Jackson ImmunoResearch, West Grove, PA, USA)).

Sections were incubated overnight (17 hours) with antibody specifically recognizing
pSTAT3 (raised in rabbit, 1:100 in incubation solution; Cell Signaling, Danvers, MA),
with biotinylated goat anti-rabbit (1:250 in incubation solution with 4% NGS, 1 hour,
Vector Laboratories), ABC-elite (1:250 in PBS, 1 hour, Vector Laboratories). Nuclear
pSTAT3 staining was visualized with 0.02% 3, 3’-diaminobenzidine tetrahydrochloride
(DAB, Sigma-Alderich) with 0.08% nickel sulfate (10 min; diluted in PB containing
0.012% H2 O2 ). Finally, sections were incubated overnight with antibody specifically
recognizing POMC (raised in rabbit, 1:120,000 in incubation solution with 4% NGS,
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Phoenix Pharmaceuticals, catalogue # H-029-30) or Kisspeptin (raised in rabbit, 1:100
000 in MBH, 1:20 000 in POA, in incubation solution with 4% NGS, gift from Dr. Alan
Caraty, France, #564) or GnRH (raised in mouse, 1:2000, in incubation solution with 4%
NGS, Covance, city, state). Next sections were incubated with biotinylated goat anti
rabbit (for POMC and Kisspeptin; 1:500 in incubation solution with 4% NGS, 1 hour,
Vector Laboratories) or biotinylated goat anti-rabbit (for GnRH; 1GOO in incubation
solution with 4% NGS, 1 hour, Vector Laboratories), with ABC-elite (1:500 in PBS, 1
hour, Vector) and with DAB to visualize reaction product (10 minutes, 0.02% diluted in
PB containing 0.012% H2 O2 ). Tissue sections were mounted onto Superfrost/Plus
Microscope Slides (Fisher Scientific), dehydrated with alcohol and cover-slipped with
Depex Mountant (Electron Microscopy Sciences, Fort Washington, PA). Specificity of
primary antibodies for POMC, Kisspepin, and GnRH have previously been demonstrated
in sheep hypothalamic sections [138, 161-162],
Control for pSTAT3 was confirmed by preabsorption with pSTAT3 immunizing peptide
(Cell Signaling, catalogue # 1195) at concentration of 1Opg/mL, for 24 h at 4° C,
eliminated all immunostaining corresponding to the appropriate antibody.

2.2.4 Analysis
Mapping: Semi-quantitative analysis was performed to analyze pSTAT3 up-regulation in
leptin versus control animals in preoptic and hypothalamic areas including DMH, VMH,
ARC, POA, AHA, PVN, LH, PVN, and PMv. Ranges o f numbers of pSTAT3-ir data
were recorded in a table.
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Quantification co-expressionpSTAT3 in GnRHneurons: All GnRH neurons in POA,
lateral hypothalamus (LH), anterior hypothalamic area (AHA), and MBH were analyzed
for co-expression of pSTAT3 using a LeicaDM5000B at 10-20x magnification.
Percentages of GnRH cells that co-expressed pSTAT3 were calculated for each brain
region for each animal. Comparisons between leptin-injected and control groups were
conducted using ANOVA with 95% confidence levels.

Quantification co-expressionpSTAT3 in Kisspeptin or POMC neurons: Numbers of
kisspeptin-ir cells and cells co-expressing kisspeptin and pSTAT3 were counted in 3
sections (one hemisphere) per animal for each rostral-middle-caudal level of the ARC and
in 3 sections per animal in the POA using Neurolucida software (Microbrightfield Inc.,
Williston, VT) attached to a motorized Leica DM5000B (Leica Microsystems,Wetzlar,
Germany) microscope and Leica DFC420 camera. Similar analysis was performed for
POMC and POMC cells co-expressing pSTAT3 in ARC. One animal in each group was
excluded due to tissue damage to the arcuate nucleus (control n=3; leptin n=3).
Percentages of kisspeptin or POMC neurons co-expressing pSTAT3 were calculated for
each animal per brain area and/or per rostral-caudal level. In the ARC, effects of
treatment and rostral-caudal level were analyzed using two way ANOVA. In POA,
treatment effects were analyzed using t-tests.

2.2.5 Images
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All images were captured using Neurolucida software (Microbrightfield Inc) attached to a
motorized Leica DM5000B (Leica Microsystems) microscope and Leica DFC420
camera. Figures were prepared using Adobe Photoshop CS2. Images were only adjusted
for brightness and contrast and not altered in any other way.
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Chapter 3. Results
3.1 IRR
IRp/AgRP and IRp/POMC
Prenatal T treatment decreased IR(3-ir in AgRP, but not POMC neurons (Fig 3.1.1). There
was a treatment effect on percentage co-expression of AgRP and IRp (F(3,66) = 8.31;
pO.OOl). In addition, there was an effect of rostro-caudal level (F(2,66) = 6.15; p =
0.004). Post hoc analysis showed that prenatal T treated group had significantly decreased
IRp/AgRP co-expression in middle (p < 0.05) and caudal (p = 0.01-0.022; Fig 3.1.2A)
subdivisions of the ARC, but not in the rostral division. There was no effect of treatment
or level on POMC co-expression with IRp (Fig 3.1.2B).

Figure3.1.1. Triple labelled Immunostaining of AgRP (green, A), POMC (blue, B), and IRp (red, C) in the
arcuate nucleus of prenatal testosterone treated ewes. Overlay image (D): Arrows - double labelled neurons,
Arrowheads - single labelled neurons. Scale bar = 10pm.
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Rostral

Mtddle

Caudal

Figure 3.1.2 Percent Colocalization of AgRP or POMC and IR(3 neurons at the level of Rostral, Middle,
and Caudal ARC. Treatment Groups were untreated control, prenatal Testosterone (T), Cotreatment of
Prenatal Testosterone and Flutamide (T+F), and Flutamide only (F). Graphs depict Mean ± SEM percent
colocalization of AgRP (A) or POMC (B) coexpressing IR0. * Significant difference from Control (p<0.05).
# Significant Difference from all other groups (p = 0.01-0.022). (AgRP Middle ARC Prenatal T: 70.99 ±
3.58; Mean ± SEM, Control: 84.02 ± 1.42, p<0.05; AgRP Caudal ARC Prenatal T: 68.06 ± 4.11, versus
Control: 82.73 ± 1.88, p = 0.01, or T+F: 82.04 ± 4.88, p = 0.013, or F 80.33 ± 2.62, p = 0.022).

3.2 pSTAT3
Mapping ofpSTAT3 in the female sheep brain
Leptin-induced pSTAT3 was observed in many areas of the brain associated with
metabolism and reproduction (Table 3.2.1). The most robust staining was observed in the
POA (Fig 3.2.1), rostral ARC, VMH (Fig 3.2.2), DMH (Fig 3.2.2 and 3.2.3), middle ARC
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(Fig3.2.3), and caudal ARC (Fig 3.2.4). Injection with leptin was required to observe
pSTAT3 staining (Fig.3.2.5).
Table 3.2.1. Characterization of leptin-induced pSTAT3-ir in the ewe.

Brain Area
Preoptic Area (POA)
Paraventricular Nucleus of the Hypothalamus (PVN)
Dorsomedial Nucleus of the Hypothalamus (DMH)
Rostral Arcuate Nuclues of the Hypothalamus (ARC)
Middle ARC
Caudal ARC
Ventromedial Nucleus of the Hypothalamus (VMH)
Ventral Premammilary Nucleus of the Hypothalamus(PMv)

Number of Cells
100-200
<5
50-100
200+
300+
200+
80-130
<5

BNST

OVLT

Figure 3.2.1 Mapping of leptin-induced pSTAT3 in POA of Sheep. Abbreviations: BNST, Bed nucleus of
the stria terminalis; ac, Anterior commisure; GP, Globus pallidus; POA, Preoptic area, OVLT, Organum
vasculosum of lamina terminalis; SI; OC, Optic Chiasm; SON, Supraoptic nucleus. One star (*) = 10
immunoreactive neurons.
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Figure 3.2.2 Mapping of leptin-induced pSTAT3 in Rostral ARC, VMH, and DMH of Sheep.
Abbreviations: mt, Mammillothalamic tract; fx, fornix; ARC, Arcuate nucleus of the hypothalamus; VMH,
Ventromedial nucleus of the hypothalamus; IC, Internal Capsule; OT, Optic tract; PT, Pituitary. One star
(*) = 10 immunoreactive neurons.
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Figure 3.2.3 Mapping of leptin-induced pSTAT3 in Middle ARC and DMH of Sheep. Abbreviations: mt,
Mammillothalamic tract; fx, fornix; ARC, Arcuate nucleus of the hypothalamus; DMH, Dorsalmedial
nucleus of the hypothalamus; 3 V, Third ventricle; CP, Cerebral peduncle. One star (*) = 10 immunoreactive
neurons.
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Figure 3.2.4 Mapping of leptin-induced pSTAT3 in Caudal ARC of Sheep. Abbreviations: : mt,
Mammillothalamic tract; fx, fornix; Cerebral peduncle, OT, Optic tract; TM, tuberomammillary nucleus;
PMv, Ventral premammilary nucleus; PMd, Dorsal premammillary nucleus; mr, mammillary recess ;ZI,
Zona incerta. One star (*) = 10 immunoreactive neurons.

51

Figure 3.2.5 Representative images of leptin-induced pSTAT3-IR (black) in the ovine ARC. Enlarged
image of the black boxes (B) are shown in panel C-D, corresponding from top to bottom, DMH (C), VMH
(D), and ARC (E). Scale bar 100 pm (A,B), 50 pm (C-E). Control animal represented in panel A.
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pSTAT3 and GNRH
Analysis of co-expression with pStat3 included 380 GnRH neurons in the POA, 163 in
AHA, 41 in MBH and 81 in the VLH, and revealed that 0% of GnRH neurons co
expressed pSTAT3-ir. Therefore, there was no effect of leptin treatment on pSTAT3
activation in GnRH neurons in the MBH or POA (Figure 3.2.6 and Fig 3.2.7,
respectively).

Figure 3.2.6: Low (A) and high power (B) views of GnRH-positive neurons and pSTAT3-positive neurons
in the ARC in leptin injected ewes. Representative images of GnRH-IR (brown) and leptin-induced
pSTAT3-IR (black) in the ovine ARC. Only single-labelled neurons were observed. Enlarged image of the
black box (B) is shown in panel A. Scale bars = 50pm( A), 25 pm (B). 3V, Third Ventricle.
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Figure 3.2.7: Low (A) and high power (B) views of GnRH-positive neurons and pSTAT3-positive neurons
in the POA in leptin injected ewes. Representative images of GnRH-IR (brown) and leptin-induced
pSTAT3-IR (black) in the ovine POA. Only single-labelled neurons were observed. Enlarged image of the
black box (B) is shown in panel A. Scale bars = 100gm(A), 50 pm (B). 3V, Third Ventricle; OVLT,
Organum vasculosum of lamina terminaiis.

pSTAT3 and Kisspeptin
Injection of leptin increased pSTAT3-ir in Kisspeptin neurons. There was a treatment
effect on percentage of co-expression of Kisspeptin neurons and pSTAT3 (F(l, 17) =
31.27; p < 0.001). There was no effect of rostro-caudal ARC level, so these areas were
averaged together. Post hoc analysis showed increased pSTAT3/kisspeptin coexpression
in the MBH (p < 0.001 compared to control) and in the POA (p = 0.029; Table 2).
There was no treatment effect on number of kisspeptin-ir. Thus, control and leptin groups
were averaged for rostro-caudal levels. There was an effect of rostro-caudal ARC level
with respect to kisspeptin-ir (F(2, 17) = 4.71; p = 0.031). Pairwise comparisons showed
increased kisspeptin-ir in middle (rostral: p = 0.012, caudal p = 0.046) subdivision of the
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ARC (Table 3.2.2). There were no differences in number of kisspeptin-ir neurons in leptin
injected animals compared to controls in the POA (Fig. 3.2.8 and 3.2.9)
Table 3.2.2 Numbers of kisspeptin-ir cells did not differ between control- or leptin-injected animals,
therefore the average number of kisspeptin-ir cells in control and leptin groups are listed for each
Rostral/Middle/Caudal level. More kisspeptin cells are found in middle ARC as described previously. #
indicates significant difference from Rostral and Cadual (rostral versus middle: p=0.012), (middle versus
caudal: p=0.046).
% Colocalization of Kisspeptin with pSTAT3 * indicates significant difference from Control. Data are
presented as Mean ± SEM

Rostral ARC
Kisspeptin 34.6 ± 14.22
% Control
0
% Leptin
7.7 ± 1.95

Middle ARC Caudal ARC Average ARC
89.7 ± 18.26# 48.0 ± 8.33
57.5 ± 16.59
0
0
0
5.5 ± 1.89
2.7 ±0.78
5.3 ±0.67*

POA
30.5 ±3.98
0
0.8 ±0.37*

Figure 3.2.8. Low (A) and high power (B) views of Kisspeptin-positive neurons and pSTAT3-positive
neurons in the ARCin leptin injected ewes. Minimal Kissl neurons in the ARC express pSTAT3.
Representative images of Kisspeptin-IR (brown) and leptin-induced pSTAT3-IR (black) in the ovine POA.
Enlarged image of the black box (B) is shown in panel A. Arrowheads denote examples of Kisspeptin-IR
neurons. Scale bars = 100 pm (A), 50 pm (B). (c) Society for Endocrinology (2011). Reproduced by
permission.
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Figure 3.2.9. Low (A) and high power (B) views of Kisspeptin-positive neurons and pSTAT3-positive
neurons in the POA in leptin injected ewes. Minimal Kissl neurons in the POA express pSTAT3.
Representative images of Kisspeptin-IR (brown) and leptin-induced pSTAT3-IR (black) in the ovine POA.
Enlarged image of the Mack box (B) is shown in panel A. Arrowheads denote examples of Kisspeptin-IR
neurons. Scale bars = 100 pm (A), 50 pm (B). Abbreviations: 3V, Third Ventricle.

pSTAT3 and POMC
Injection of leptin increase pSTAT3-ir in POMC neurons. There was a treatment effect on
percent of co-expression of POMC neurons and pSTAT3 (F( 1,17); p < 0.001). There was
an effect of rostro-caudal ARC level in percent of co-expression of POMC neurons with
pSTAT3 (F(2,17; p = 0.004). Pairwise comparisons showed increased POMC-ir in all
rostro-caudal ARC levels compared to controls (p < 0.001; Table 3). Rostral and Middle
ARC levels had significantly higher co-expression of POMC with pSTAT3 compared to
the Caudal level in leptin injected animals (p < 0.001 and 0.002, respectively) (Table
3.2.3).There was no treatment effect in number of POMC-ir neurons comparing leptin
and control groups. There was an effect of ARC rostro-caudal level with respect to
POMC-ir (F(2,17) = 4.30; p = 0.039). Pairwise comparisons showed increased POMC-ir
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neurons in rostral and middle ARC compared to caudal (p = 0.037, p = 0.019,
respectively) (Fig 3.2.10).
Table 3.2.3 % Colocalization of POMC with pSTAT3 * (p<0.001) = difference from Control (Effect of
treatment). Effect of ARC level: # (p<0.05) = difference from Rostral and Middle
Number of immunoreactive POMC neurons ** (p<0.05) = difference from Rostral and Middle

POMC neurons
% Control
% Leptin

Rostral ARC
214.3 ±28.49
0
30.2 ±2.33*

Middle ARC
226.9 ±22.59
0
25.7 ± 1.64*

Caudal ARC
129.8 ±20.33**
0
16.0 ±3.02*#

Figure 3.2.10. Low (A) and high power (B) views of POMC-positive neurons and pSTAT3-positive
neurons in the rostral arcuate nucleus in leptin injected ewes. Colocalization of pSTAT3 within POMC
neurons were observed. Representative images of POMC-IR (brown) and leptin-induced pSTAT3-IR
(black) in the ovine ARC. Enlarged image of the black box (B) is shown in panel A. Both single(arrowheads) and dual-labelled (arrows) neurons can be seen. Scale bar = 100pm(A), 50 pm (B).
Abbreviations: 3V, Third Ventricle.
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Chapter 4: Disscussion
4.1 IR 0 data
Changes in IRB in AgRP cells - what do they mean?
The findings from this study provide evidence of long term changes in the colocalization
of the insulin receptor (IR) within AgRP neurons, as a consequence of exposure to
prenatal testosterone. Prenatal T treatment significantly decreased percentage of AgRP
neurons colocalizing IR in the middle division of the ARC compared with controls.
Although IR coexpression was increased by co-treatment with the androgen receptor
antagonist flutamide this change did not reach significance. Previously, we found a
significant increase in AgRP-ir in the middle division of the ARC where double the
number of AgRP-ir neurons were observed in prenatal T treated sheep compared to
controls. This increase was partially rescued by co-treatment of prenatal T with flutamide
[ 1].

The contribution of T being aromatized to E remains an additional possible mechanism
for modulation of the metabolic circuitry, as a proportion of NPY, the orexigenic peptide
that is coexpressed with AgRP. is known to colocalize ERa in the ARC of sheep [2],
Therefore, the increase in AgRP can be contributed to the androgenic actions of prenatal
T exposure, evident by the partial rescue o f AgRP increase by co-treatment with
flutamide. Since the decrease in the percentage of AgRP colocalizing IR in the middle
division of the ARC was not rescued by co-treatment with flutamide, it can be postulated
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that this effect is at least partially due to aromatization of testosterone to estrogen, and
thus is a result of both the estrogenic and androgenic action of testosterone [3],
In addition to insulin and its receptor, other factors may synergistically contribute to the
observed increase in AgRP in the middle division of the ARC in this model. AgRP
neurons are also modulated by leptin (suppresses AgRP/NPY), the gut protein ghrelin
(upregulates AgRP expression), and glucocorticoids (increase AgRP) [4-6]. Plasma leptin
levels are elevated in women with PCOS [7], Although no differences in ghrelin levels in
PCOS women have been found, adolescents with PCOS have decreased ghrelin
suppression after glucose load and this may lead to overconsumption during meals,
contributing to increased weight gain [8]. In addition, it has been shown that
glucocorticoids upregulate AgRP expression in the rat ARC [9]. It is possible that the
AgRP neuronal population in the middle ARC may be regulated by multiple peripheral
factors, including leptin, ghrelin, and glucocorticoids and exposure to excess testosterone
in utero may modulate the interaction of these signals to these neurons.

Prenatal T treatment significantly decreased insulin receptor colocalization with AgRP in
the caudal division of the ARC. This was rescued by co-treatment with the androgen
receptor antagonist flutamide. Previously, we did not observe any significant differences
in AgRP-ir in the caudal aspect of the ARC with prenatal T treatment. Therefore, prenatal
T treatment decreases IR in the caudal aspect of the ARC without altering AgRP-ir in this
region. This suggests that additional factors, such as those stated above, may be involved
in the increased AgRP-ir seen in the middle ARC of prenatal T animals.
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Since there was no increase in AgRP despite the decreased IR, it is possible that other co
expressed neuropeptides are affected, for example, NPY. We know thatNPY and AgRP
are colocalized 95% in the ewe ARC [1]. We also know that insulin suppresses NPY gene
expression [10]. It is possible that the effects of insulin upon AgRP/NPY neurons in the
caudal division of the ARC are predominantly focused on NPY rather than AgRP. It is
not known if there are functional differences among AgRP/NPY neurons between middle
and caudal levels of the ARC.

In one study, it was shown that intact male rats have an increased NPY mRNA expression
in the caudal division of the ARC compared to intact female rats [11]. It would be of
interest to investigate the effect on prenatal T exposure on NPY expression in female
sheep, to see if this treatment mimics the organizational effect of T in masculinizing NPY
expression in the ARC. The effect of testosterone on this neuronal population in female
sheep may result in decreased IR in this neuronal population, disinhibiting NPY neurons
by insulin, and possibly result in increased expression.

Are there changes in AsRP in other regions/tissues?
In addition to the hypothalamus, AgRP is also expressed in the subthalamic nucleus
however the function is not known. Moreover, the major site physiological function of
AgRP is the ARC. The adrenal gland, testis, lung, and dorsal root ganglia also exhibit the
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AgRP transcript, but a shorter transcript that lacks the 5” noncoding exon [12]. Very few
studies have focused on AgRP action outside of the hypothalamus, and thus its function
in the periphery in largely unknown. However, it is believed that AgRP in the periphery is
involved in orexigenic activity in energy balance and adrenal function [13]. The effect of
prenatal androgen exposure on AgRP in the periphery has not been examined.

Any evidence o f chanses in AsRP in PCOS?
While there is no evidence of changes in AgRP expression in women with PCOS
independent of BMI, women with PCOS were found to have elevated plasma NPY levels
compared to controls [14]. The sheep in the present study are on a maintenance diet to
sustain normal body weight. It is unlikely that the plasma NPY reflects hypothalamic
levels, instead circulating NPY probably arises from the pancreas or adrenal [14], Thus,
NPY may be elevated in these peripheral tissues in prenatal T sheep. It would be of
interest to look at NPY and AgRP expression in this animal model compared to the diet
induced obesity (DIO) prenatal T sheep model to determine if changes in these
neuropeptides are associated with exacerbation of the metabolic and reproductive
phenotype linked with the addition of obesity [15].

Similarities between effects o f prenatal T on insulin signaling between brain and
periphery
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The present study shows that at the level of the brain, insulin resistance may also
contribute to the metabolic phenotype. In the same model, it has previously been shown
that prenatal T treatment results in peripheral insulin resistance in addition to decreased
IR in the liver [16]. The liver is an important metabolic organ and insulin secretion
normally suppresses hepatic glucose production [17].

In mice, when IR are knocked out of AgRP neurons only, hepatic glucose production
increased in response to insulin [18]. When IR was restored in these neurons, hepatic
glucose production was decreased in response to insulin [19]. Therefore coexpression of
IR in AgRP neurons in mice is an important modulator of hepatic glucose production in
the liver. We see a decrease in IR in AgRP in the prenatal T animals in addition to
decreased IR in the livers of these animals [16]. However, considering the modest
decrease in AgRP-IR colocalization in these animals, it is unlikely that the reduced IR in
the liver is a direct result of central IR decrease. Nevertheless, it is important to note that
similar changes seen in IR in the hypothalamus have also been observed peripherally.

In the present study we observed a significant but relatively modest decrease in insulin
receptor colocalization with AgRP. Thus it is likely that other aspects of the insulin
pathway may mediate the dramatic increase in AgRP immunoreactive neuron expression
found in this animal model. Possibly, downstream signaling molecules in the insulin
receptor pathway are affected. In addition to decreased IR in the liver, prenatal T sheep
have decrease in IRS-II, AKt, mTOR, PPAR-y mRNAs in this organ, all important
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components of the insulin pathway [16]. Investigating the downstream insulin signaling
pathway in AgRP/NPY neurons would be beneficial to further understanding the insulin
resistance in the brain conferred by excess prenatal testosterone exposure.

Why did we not see any changes in POMC neurons?
In contrast to AgRP neurons, we saw no significant changes in POMC neurons, either in
the number of POMC neurons or in their degree of insulin receptor co-expression. In rats,
it was previously shown that when POMC IR neurons are knocked out, there is no
metabolic or reproductive disturbances [18]. Although insulin and POMC both act
anorectically, insulin may not play a role in POMC to product this effect, but instead
other hormones, such as leptin, may act on POMC to decrease food intake and increase
energy expenditure (Summarized in Figure 4.1).

63

Prenatal Testosterone M odel

Second order
neurons (PV N ,
D M H , LH)

Qq ,
(g

M CR4
M CR3

ß

In sulin R e cep to r

II

Lep tln R e cep to r

Insulin
Resistance

Figure 4 .1. Effect of excess prenatal T exposure on metabolic neuronal circuitry in the female sheep ARC.
Abbreviations: ARC, arcuate nucleus; 3V, third ventricle; AgRP, agouti-related peptide; POMC,
proopiomelanocortin; MCR3, meianocortin receptor 3; MCR4, melanocortin receptor 4; PVN,
paraventricular nucleus; LH, lateral hypothalamus; DMH, dorsomedial hypothalamus. (Modifiedfrom
Barsh and Schwartz, 2002)

Does prenatal T affect 1R in other neuronal populations?
The current work represents a start in the phenotypic characterization of ARC and other
hypothalamic neurons that coexpress IR. Whether GnRH neurons coexpress IR in vivo is
currently not known. Although a GnRH expressing conditionally immortalized cell line
has been shown to respond to insulin, this cell line is derived from embryos and has been
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shown to display marked phenotypic differences from adult GnRH cells [20]. Therefore,
extrapolating from this cell line to animals requires in vivo experiments. Another
population which may be a direct target of insulin are KNDy (kisspeptin, neurokinin B,
dynorphin) cells of the ARC. However, it was reported that insulin infusion does not
modulate kisspeptin gene expression in a diabetic rat model or murine hypothalamic cell
line [21, 22], Furthermore, it has been shown that during lactation, when insulin and
kisspeptin, and NPY mRNA are suppressed, restoring insulin did not affect the expression
of these peptides [23], Thus, evidence to date suggests kisspeptin may not be modulated
by insulin, although neurokinin B and dynorphin have yet to be examined.

AsRP may also relay metabolic status to the reproductive neuroendocrine system.
While the effects of AgRP/NPY in the hypothalamus on metabolic function have been
widely studied, this neuron population may also be a link by which metabolic and
nutritional cues modulate the reproductive neuroendocrine system. NPY fibers have been
observed in close apposition with GnRH neurons in the OVLT/POA and ME. Although
GnRH cell bodies have not been shown to colocalize the NPY receptor (Yl), GnRH
fibers and terminals positively stain for Yl [24] suggesting possible axo-axonic
interactions at the level of the ME. Furthermore, kisspeptin neurons in the ARC of the
ewe and mouse have been shown to reciprocally communication with NPY neurons,
although additional studies on the mechanism of this signaling are required [25, 26].
Consequently, the AgRP/NPY neuron population in the hypothalamus may additionally
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serve as indicators of metabolic status, conveying that information to the reproductive
neuroendocrine system.

4.2 pSTAT3 as a marker for leytin-responsive cells in the sheep hypothalamus
Given the effects of leptin on the reproductive neuroendocrine system, it was of interest
for us to examine GnRH and kisspeptin cells as potential targets.
In the present study, we found no colocalization of pSTAT3 with GnRH. It has been
shown in other species that GnRH neurons do not colocalize the leptin receptor [21].
Therefore, our results are consistent with the view that leptin’s influence on GnRH
neuroendocrine secretion and the reproductive axis must be indirect via afferent neurons.

We then looked at kisspeptin neurons in the ARC and POA. We observed almost no
colocalization of kisspeptin and pSTAT3 in kisspeptin cells of the POA (<1%) which is
consistent with rodent AVPV data [28], We observed <8% colocalization of ARC
kisspeptin neurons with pSTAT3. This result is differs from the % of kisspeptin neurons
in the mouse that were shown to coexpress LepRb (40%) by dual in situ hybridization
[29] but consistent with transgenic mouse experiments that have shown only 5-6%
colocalization of Kisspeptin with LepRb [28], Therefore, kisspeptin neurons may be
activated by leptin, but this activation is likely indirect and mediated by upstream
neurons.

We have shown that -30% of POMC neurons colocalize pSTAT3, and we have
preliminary evidence that in the sheep, almost all AgRP neurons colocalize pSTAT3. It
has also been shown that both AgRP and POMC neurons make contacts with kisspeptin,
thus, leptin may control the reproductive axis indirectly through POMC/AgRP neurons
which then act on kisspeptin, which then acts on GnRH [25, 26] (Summarized in Figure
4.2).

Effect of Leptin on Neuroendocrine Reproductive Axis

Figure 4.2. Proposed connections of ARC neurons of the ewe regulating metabolism and reproduction.
Abbreviations: ARC, arcuate nucleus; AgRP, agouti-related peptide; POMC, proopiomelanocortin; KNDy,
Kisspeptin/Neurokinin B/Dvnorphin; GnRH, gonadotropin releaseing hormone.
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Future studies would include comparing expression of leptin-induced Fos, and leptininduced pSTAT3 in the same neurons to distinguish between direct and indirect actions.
We have shown that there is very low colocalization between kisspeptin and pSTAT3.
pSTAT3 is an indicator of direct leptin action via LepRb, whereas Fos may be a reflection
of either direct action (gene expression due to LepRb-pSTAT3 signaling) or indirect
activation via glutamatergic or other afferents. For example, Fos may be increased in
kisspeptin neurons due to interaction with either POMC or AgRP neurons. Directly
comparing direct vs. indirect actions of leptin at a cellular level should help further
elucidate the role of leptin in communicating energy stores to the reproductive axis.

What other leptin-resyonsive populations may be important in conveying leptin’s
influence on reproduction?
Leptin receptors have been observed in additional hypothalamic nuclei, and in the present
study, we showed that leptin induced pSTAT3 was evident in the VMH and DMH. The
VMH has been shown to respond to insulin and glucose, whereas DMH innervates areas
in the brain involved in reproduction [30]. Therefore, there is evidence that leptin targets
additional areas in the brain, however, its impact on reproduction in these areas must still
be investigated.

Is leytin-resvonsiveness altered in prenatal T and PCOS?
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Obese women with PCOS had increased circulating leptin compared to controls, but
leptin in non-obese PCOS women did not show differences from controls. Therefore,
leptin is correlated with BM1 in women with PCOS. Although lean PCOS women did not
show a significant difference in plasma leptin, there was a significant positive correlation
between testosterone and leptin [14]. Serum and follicular fluid concentrations of leptin in
granulosa cells of ovarian follicles were significantly higher in PCOS women with failed
pregnancy compared to PCOS women who successfully got pregnant. Also, pSTAT3
expression was significantly lower in the granulosa cells of PCOS women with failed
pregnancy compared to both PCOS women with successful pregnancy and control
women with successful and failed pregnancy. Overall, it was shown that pSTAT3
expression in granulosa cells of PCOS women was decreased compared to control women
[31],Consequently, large scale studies in women with PCOS (incorporating prevalence of
obesity and BMI) are required to further characterize the correlation of leptin and
additional biochemical levels to clarify the role of leptin in the metabolic and
reproductive features of this disease.

4.3 Overall discussion o f effect o f leptin and insulin on the reproductive and metabolic
system

Prenatal T: amplification o f its effects by obesity
Excess postnatal weight gain exaggerates reduced insulin sensitivity. Overfeeding of
prenatal T animals and controls manifested impaired insulin sensitivity and this was
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observed to occur earlier in the prenatal T animals. It remains to be determined if
postnatal overfeeding of prenatal T animals results in an exacerbated phenotype in
adulthood [15]. However, recent research in human PCOS patients demonstrates that
obesity exacerbates the characteristic phenotypes expressed, including infertility and that
lifestyle management, such as weight loss and exercise, can improve the metabolic and
reproductive features of PCOS [32],

Will changes in IR and/or AsRP be exacerbated by ad lib feeding
The animals in used in the present study are put on a weight management diet so that they
do not become obese; however, we know postnatal overfeeding of prenatal T sheep
rapidly affects insulin sensitivity [15]. The effect of overfeeding on prenatal T sheep
AgRP and POMC neuronal population is currently not known. To follow up on this, it
would be of importance to look at POMC and AgRP immunoreactivity, pSTAT3 and IR
in these animals. Obese control, female sheep have been shown to have decreased AgRPir, opposite to that observed in prenatal T animals, as well as increased POMC-ir
(Sheppard, K.M. Abstract # 2008-13219-SFN). Whether obesity exacerbates or reverses the
neuronal metabolic phenotype of prenatal T sheep is a key next step in characterizing this
model and its relationship to the pathogenesis of PCOS.

Can diet restriction be used as an intervention in prenatal T animals, and as possible
treatment in PCOS?
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The first step in treatment of the metabolic component of the PCOS phenotype is to lose
weight through exercise and food restriction. However, it is under the control of human
beings to do this. Considering over 50% of women with PCOS are obese, and 70% are
insulin resistant, a sheep model of dietary restriction would further elucidate the
implications of lifestyle interventions, such as improved fertility and decreased transfer of
harmful metabolic phenotypes to the offspring [33, 34], The offspring of overweight
control sheep show impaired insulin sensitivity [15]. It is possible that the effects of
postnatal overfeeding in prenatal T sheep, resulting in postnatal weight gain, may be
transferred transgenerationally to the respective offspring. Amplification of the metabolic
and reproductive dysfunctions in the prenatal T model may be reduced through lifestyle
modifications, including dietary restriction.

4.4 Conclusion
It is evident that the aetiology of PCOS involves a complex interplay of many factors.
The reproductive and metabolic dysfunction and their interaction associated with this
disease further complicate the overall understanding of PCOS. Investigating possible
components of insulin resistance in the prenatal T sheep will help further the
understanding of one of the major contributors to the phenotype features of PCOS. Insulin
resistance, and thus compensatory hyperinsulinemia, plays a major role in perpetuating
hyperandrogenemia, decreasing hepatic sex hormone binding globulin, and exacerbating
ovarian follicle arrest [35-37]. The possibility of insulin resistance at the neuronal level of
the brain in an animal model of PCOS has not been explored until the present study. We

71
found a significant decrease in insulin receptors colocalized to AgRP neurons in prenatal
T sheep, suggesting that this decrease may contribute to the insulin resistance seen in this
model, in this case manifested in the brain instead of the periphery.

Characterization of pSTAT3 as a marker for leptin signaling in the brain of the ewe has
not been published until this study. Identifying neurons activated by leptin will help
further elucidate the effect of this hormone on both the reproductive and metabolic
systems. Based on this characterization, a future step will be to identify possible changes
in leptin responsiveness in the prenatal T sheep model. Leptin is an important metabolic
signal of energy stores and an indicator to the reproductive axis whether sufficient stores
are available to permit reproduction[38]. The metabolic and reproductive axes of these
systems are dysfunctional in this model and in humans with PCOS [39]. Since leptin links
these two axes, and plasma leptin levels are elevated in humans with PCOS, it would be
beneficial to determine the mechanisms by which prenatal T exposure effects leptin
signaling in the brain[14].

PCOS is the most common endocrine disorder in women and can result in a higher
prevalence co-morbidities, including dysfunctional fertility, cardiovascular disease, type 2
diabetes mellitus, obstetrical complications, psychiatric and neurological disorders, and
malignancies [40]. Investigating the dysfunctions associated with PCOS can help set into
place interventions to prevent the onset of these co-morbidities. Our hope is that by
identifying the basic mechanisms involved in the long term changes induced by prenatal
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T exposure, we will identify targets for clinical intervention at the level of the brain, as
well as periphery.
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Appendices:
Appendix 1. Antibody Controls
The specificity of the antibody used for IR was verified by preabsorbing the diluted
primary antibody with immunizing peptide (Santa Cruz) at a concentration of lOg/ml (Fig
A .l), which effectively eliminated all neuronal immunostaining corresponding to IR-ir.

Figure A.l Preabsorption control for IR antibody (1:300; A) and peptide antigen at concentration of lOg/ml
(B) Scale bar = lOpm

The specificity of the antibody used for pSTAT3 was verified by preabsorbing the diluted
primary antibody with immunizing peptide (Cell Signaling) at a concentration 5g/ml (Fig
A.2), which effectively eliminated all immunostaining corresponding to pSTAT3-ir.
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Figure A.2 Preabsorption control for pSTAT3 antibody (1:100; A) and peptide antigen at concentration
5g/ml (B). Scale bar = 100pm
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Protocol Number: #10086
Approval Period: 08/07/2008 - 08/07/2011
Funding Agency: National Institutes of Health
Title: Prenatal Programming of Reproductive Health and Disease
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Date: 08/07/2008
Dear Principal Investigator,
The University of Michigan Committee on Use and Care of Animals (UCUCA)
has reviewed your application to use vertebrate animals (Application
#10086). This project has been approved. The proposed animal use
procedures are in compliance with University guidelines, State and
Federal regulations, and the standards of the "Guide for the Care and
Use of Laboratory Animals."
When communicating with the UCUCA Office please refer to the Approval
Number #10086. The approval number must accompany all requisitions for
animals and pharmaceuticals.
The approval date is 08/07/2008. The approval period is for three years

from this date. However, the United States Department of Agriculture
(USDA) requires an annual review o f applications to use animals.
Therefore, each year of this application prior to the anniversary of its
approval date, you will be notified via email to submit a short annual
review. Your continued animal use approval is contingent upon the
completion and return of this annual review. You will also be notified
120 days prior to the expiration of the approval period so that your
renewal application can be prepared, submitted and reviewed in a timely
manner in the eSirius program and an interruption in the approval status
of this project avoided.
UCUCA approval must be obtained prior to changes from what is originally
stated in the protocol. An amendment must be submitted to the UCUCA for
review and approved prior to the implementation of the proposed change.
The University's Animal Welfare Assurance Number on file with the NIH
Office of Laboratory Animal Welfare (OLAW) is A3114-01, and most recent
date of accreditation by the Association for the Assessment and
Accreditation of Laboratory Animal Care International (AAALAC, Inti.) is
March 10, 2008.
If you receive news media inquiries concerning any aspect of animal use
or care in this project, please contact James Erickson, News and
Information Services. If you have security concerns regarding
the animals or animal facilities, contact Bill Bess, Director of Public
Safety.
Sincerely,
Susan Stem, MD
Associate Professor, Emergency Medicine
Chairperson, University Committee on Use and Care of Animals
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